Clinical trial
Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck…
NCT00003443 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003443 |
|---|---|
| Title | Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer |
| Official title | A Phase II Trial of Bryostatin-1 In Patients With Metastatic or Recurrent Squamos Cell Carcinoma of the Head and Neck |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | bryostatin 1 |
| Start date | Jul 1, 1998 |
| Primary completion | May 1, 2001 |
| Completion | May 1, 2001 |
| First posted | Jun 3, 2004 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: